Ignite Creation Date:
2025-12-25 @ 2:45 AM
Ignite Modification Date:
2026-02-21 @ 6:49 PM
Study NCT ID:
NCT02480933
Status:
UNKNOWN
Last Update Posted:
2017-11-28
First Post:
2015-06-17
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Silent Breast Cancer A Study of the Disease Prevalence Held by Imaging Guided Biopsies in Autopsy Specimens
Sponsor:
Centro Hospitalar Lisboa Ocidental
Organization:
Study Overview
Official Title:
Silent Breast Cancer A Study of the Disease Prevalence Held by Imaging Guided Biopsies in Autopsy Specimens
Status:
UNKNOWN
Status Verified Date:
2017-11
Last Known Status:
ACTIVE_NOT_RECRUITING
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
SISYPHUS
Brief Summary:
The aim of this study is to define silent breast cancer prevalence in both sexes and will be held by biopsies performed in imaging suspicious areas of the breast (ecography and mammography) in cadavers without known breast cancer.
Detailed Description:
Cadavers of both sexes are going to be submitted to bilateral mastectomy. The specimens are going to be examined by palpation, ecography and mammography and all areas with (Breast Imaging Reporting and Data System) BI-RADS classification \>= 3 are going to be biopsied.
Biopsy specimens are going to be processed by the pathology department and cancers are going to be identified and classified by their molecular type.
The investigators intend to know which is the disease reservoir in various ages.
Biopsy specimens are going to be processed by the pathology department and cancers are going to be identified and classified by their molecular type.
The investigators intend to know which is the disease reservoir in various ages.
Study Oversight
Has Oversight DMC:
False
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: